JACKSON, Miss. - Mississippi hospitals are administering a new monoclonal antibodies therapy to COVID-19 patients with hope of improved outcomes and limite hospitalizations while the virus is back on the rise, again. Monoclonal antibodies were approved Nov. 21 by the U.S. Food and Drug Administration. The therapy can be used for high-risk patients who have tested positive, but not yet been hospitalized. The one dose is administered intravenously and can be used in individuals ages 12 and older. George Regional Hospital in Lucedale administered the treatment for the first time for two COVID-19 positive patients on Nov. 24. Days later, both patients were doing well, according to GRH Chief of Staff Dr. Jay Pinkerton. The treatment is the latest in a string of "good science" coming out to help physicians fight the virus, he said. (Source: The AP 11/28/20)
No comments:
Post a Comment